Application of thiourea polyurethane foam/zinc oxide nanocomposite for anticancer effects and antimicrobial potential
Mohamed M. El‐Zahed, Mai S. Eissa, E.A. Moawed, Rana R. El Sadda
Abstract
Abstract There is a continuous need to fabricate new antimicrobial agents due to the continuous development of microbial drug resistance. Recently, zinc oxide nanoparticles (ZnONPs) have emerged as a promising choice for developing new drugs owing to their exceptional broad-spectrum antimicrobial and anticancer action. In the current work, thiourea polyurethane foam/zinc oxide nanocomposite was synthesized by coupling ZnONPs and thiourea polyurethane foam (TPUF) to test its antimicrobial and anticancer activities. Ultraviolet–visible spectra, Fourier transform infrared, X-ray diffraction (XRD), zeta potential and dynamic light scattering analyses were investigated to study the characterization of thiourea polyurethane foam/zinc oxide nanocomposite (TPUF/ZnO). The synthesized TPUF/ZnO was examined as an antimicrobial agent against gram-positive bacterium ( Bacillus cereus ), gram-negative bacterium ( Escherichia coli ), and fungus ( Aspergillus niger ). The results of the agar well-diffusion test showed good inhibition zones against E. coli (16 mm), B. cereus (13 mm), and A. niger (26 mm). The minimum inhibition concentration (MIC) values of TPUF/ZnO against B. cereus and E. coli were 350 μg/mL and 400 μg/mL. TEM of TPUF/ZnO-treated B. cereus and E. coli bacteria displayed different ultrastructural modifications such as separation of the plasma membrane from the cell wall and vacuole formation that led to a complete lysis and bacterial death. The anticancer activity of TPUF/ZnO was also evaluated against liver and breast cancer cell lines (HepG-2 and MCF-7). TPUF/ZnO showed good cytotoxicity activities against HepG-2, and MCF-7, with IC 50 values of 77.08 ± 1.36 and 109.01 ± 3.98 µg/ml, respectively. Thus, TPUF/ZnO could be a promising raw material in the field of food packaging and provide a possible anticancer compound for hepatocellular carcinoma and breast carcinoma. Graphic abstract